MOESM1 of DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation

Ssu Chuan Lai (Contributor)
Yu Ting Su (Contributor)
Ching Chi Chi (Contributor)
YungChe Kuo (Contributor)
Kam Fai Lee (Contributor)
Yu-Chih Wu (Contributor)
Pei Chi Lan (Contributor)
Muh Hwa Yang (Contributor)
Te Sheng Chang (Contributor)
Yen Hua Huang (Contributor)

資料集

Description

Additional file 1. Supplementary information.

可用日期	1月 1 2019
發行者	Unknown Publisher

DOI
10.6084/m9.figshare.11273585.v1

存取資料集

https://springernature.figshare.com/articles/MOESM1_of_DNMT3b_OCT4_expression_confers_sorafenib_resistance_and_poor_prognosis_of_hepatocellular_carcinoma_through_IL-6_STAT3_regulation/11273585/1

1 文章

DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation
Lai, S. C., Su, Y. T., Chi, C. C., Kuo, Y. C., Lee, K. F., Wu, Y. C., Lan, P. C., Yang, M. H., Chang, T. S. & Huang, Y. H., 11月 26 2019, 於: Journal of Experimental and Clinical Cancer Research. 38, 1, 474.
研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取
25 引文斯高帕斯（Scopus）

引用此

Lai, S. (Contributor), Su, Y. (Contributor), Chi, C. (Contributor), Kuo, Y. (Contributor), Lee, K. (Contributor), Wu, Y. (Contributor), Lan, P. (Contributor), Yang, M. (Contributor), Chang, T. (Contributor), Huang, Y. (Contributor) (1月 1 2019). MOESM1 of DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation. Unknown Publisher. 10.6084/m9.figshare.11273585.v1

MOESM1 of DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation

Description

DOI

存取資料集

研究成果

DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation

引用此